# North China Pharmaceutical Group Hualuan Co., Ltd – FDA Inspection, Nov 29, 2013

Source: https://www.keypedia.com/records/fda_inspections/north-china-pharmaceutical-group-hualuan-co-ltd/c0fd6a3d-a34d-47d6-ae0d-f41b9f3ff252
Source feed: FDA_Inspections

> FDA inspection 866089 of North China Pharmaceutical Group Hualuan Co., Ltd, November 29, 2013. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 866089
- Company Name: North China Pharmaceutical Group Hualuan Co., Ltd
- Inspection Date: 2013-11-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 957493 - 2015-12-17](https://www.keypedia.com/records/fda_inspections/north-china-pharmaceutical-group-hualuan-co-ltd/ce0ad9c8-5400-4bf0-a160-7777858d6505)
- FDA Inspection 629864 - 2009-09-10

Company: https://www.keypedia.com/companies/north-china-pharmaceutical-group-hualuan-co-ltd/3f6c6731-a616-4e5d-b2eb-10b0b1ca492c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c